Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-155,390
Closed -$11.7M 200
2026
Q1
$11.7M Sell
155,390
-12,995
-8% -$977K 0.23% 92
2025
Q4
$12.5M Sell
168,385
-60
-0% -$4.38K 0.22% 99
2025
Q3
$11.4M Buy
168,445
+16,370
+11% +$1.09M 0.19% 111
2025
Q2
$9.91M Hold
152,075
0.17% 123
2025
Q1
$9.39M Hold
152,075
0.16% 122
2024
Q4
$11M Sell
152,075
-60
-0% -$4.69K 0.18% 122
2024
Q3
$12.4M Sell
152,135
-3,345
-2% -$268K 0.2% 108
2024
Q2
$11.5M Sell
155,480
-85
-0.1% -$6.37K 0.19% 111
2024
Q1
$12.1M Hold
155,565
0.2% 109
2023
Q4
$11.1M Hold
155,565
0.2% 108
2023
Q3
$10.8M Hold
155,565
0.22% 106
2023
Q2
$12.6M Buy
155,565
+12,370
+9% +$1.01M 0.24% 101
2023
Q1
$11.6M Buy
143,195
+50
+0% +$4.03K 0.23% 106
2022
Q4
$10.7M Hold
143,145
0.23% 107
2022
Q3
$9.24M Hold
143,145
0.21% 113
2022
Q2
$9.92M Sell
143,145
-57,300
-29% -$4.25M 0.22% 112
2022
Q1
$15.4M Sell
200,445
-21,670
-10% -$1.56M 0.27% 98
2021
Q4
$17M Sell
222,115
-25
-0% -$1.84K 0.28% 98
2021
Q3
$16.4M Sell
222,140
-100
-0% -$7.5K 0.29% 101
2021
Q2
$14.8M Buy
222,240
+1,300
+0.6% +$86.9K 0.26% 112
2021
Q1
$16.4M Sell
220,940
-3,880
-2% -$295K 0.31% 94
2020
Q4
$16.4M Buy
224,820
+100
+0% +$7.06K 0.31% 92
2020
Q3
$14.9M Buy
224,720
+6,460
+3% +$409K 0.31% 92
2020
Q2
$12.4M Buy
+218,260
New +$10.7M 0.29% 98

Other funds holding HOLX

Nicholas Company's HOLX Position: Q2 2026 in Review

Nicholas Company sold out of Hologic (HOLX) in Q2 2026, closing a stake of 155,390 shares — an estimated $11.7M sold.

Nicholas Company first reported a position in HOLX in Q2 2020 and held it in 24 quarters. The position peaked at $17M in Q4 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Nicholas Company reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Nicholas Company sold 155,390 Hologic shares in Q2 2026, an estimated $11.7M.
  • Nicholas Company first reported a position in Hologic in Q2 2020 and held it in 24 quarters.
  • Nicholas Company's Hologic position peaked at $17M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.